6-HydroxykaempferolCAS# 4324-55-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 4324-55-4 | SDF | Download SDF |
PubChem ID | 5281638 | Appearance | Yellow powder |
Formula | C15H10O7 | M.Wt | 302.2 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3,5,6,7-tetrahydroxy-2-(4-hydroxyphenyl)chromen-4-one | ||
SMILES | C1=CC(=CC=C1C2=C(C(=O)C3=C(C(=C(C=C3O2)O)O)O)O)O | ||
Standard InChIKey | LFPHMXIOQBBTSS-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 6-Hydroxykaempferol is a competitive inhibitor of tyrosinase compared to L-DOPA, it shows also high antioxidant activities. |
Targets | Tyrosinase |
6-Hydroxykaempferol Dilution Calculator
6-Hydroxykaempferol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.3091 mL | 16.5453 mL | 33.0907 mL | 66.1813 mL | 82.7267 mL |
5 mM | 0.6618 mL | 3.3091 mL | 6.6181 mL | 13.2363 mL | 16.5453 mL |
10 mM | 0.3309 mL | 1.6545 mL | 3.3091 mL | 6.6181 mL | 8.2727 mL |
50 mM | 0.0662 mL | 0.3309 mL | 0.6618 mL | 1.3236 mL | 1.6545 mL |
100 mM | 0.0331 mL | 0.1655 mL | 0.3309 mL | 0.6618 mL | 0.8273 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Formoterol Hemifumarate
Catalog No.:BCC4349
CAS No.:43229-80-7
- Fenbendazole
Catalog No.:BCC1236
CAS No.:43210-67-9
- Skp2 Inhibitor C1
Catalog No.:BCC6298
CAS No.:432001-69-9
- 6-(5-Chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
Catalog No.:BCC8753
CAS No.:43200-81-3
- Zopiclone
Catalog No.:BCC9195
CAS No.:43200-80-2
- Allylestrenol
Catalog No.:BCC8814
CAS No.:432-60-0
- SJ 172550
Catalog No.:BCC2416
CAS No.:431979-47-4
- 7'-O-Ethylmarmin
Catalog No.:BCC8274
CAS No.:
- Necrostatin-1
Catalog No.:BCC2247
CAS No.:4311-88-0
- DPO-1
Catalog No.:BCC7398
CAS No.:43077-30-1
- Umckalin
Catalog No.:BCC9211
CAS No.:43053-62-9
- Deoxyshikonin
Catalog No.:BCN3006
CAS No.:43043-74-9
- Boc-Tyr-OMe
Catalog No.:BCC3459
CAS No.:4326-36-7
- Toddaculine
Catalog No.:BCN3639
CAS No.:4335-12-0
- 3-O-Acetyloleanolic acid
Catalog No.:BCN5486
CAS No.:4339-72-4
- VU 0357121
Catalog No.:BCC4595
CAS No.:433967-28-3
- Ethisterone
Catalog No.:BCC4478
CAS No.:434-03-7
- Methenolone acetate
Catalog No.:BCC9028
CAS No.:434-05-9
- Oxymetholone
Catalog No.:BCC4692
CAS No.:434-07-1
- Lithocholic Acid
Catalog No.:BCC3805
CAS No.:434-13-9
- Nandrolone
Catalog No.:BCC9086
CAS No.:434-22-0
- Dacarbazine
Catalog No.:BCC1174
CAS No.:4342-03-4
- K 41498
Catalog No.:BCC5867
CAS No.:434938-41-7
- L-5-Hydroxytryptophan
Catalog No.:BCC8106
CAS No.:4350-09-8
Inhibitory effects of 5,6,7-trihydroxyflavones on tyrosinase.[Pubmed:17693955]
Molecules. 2007 Jan 29;12(1):86-97.
Baicalein (1), 6-hydroxyapigenin (6), 6-hydroxygalangin (13) and 6-hydroxy-kaempferol (14), which are naturally occurring flavonoids from a set of 14 hydroxy-flavones tested, exhibited high inhibitory effects on tyrosinase with respect to L-DOPA, while each of the 5,6,7-trihydroxyflavones 1, 6, 13 or 14 acted as a cofactor to monophenolase. Moreover, 6-Hydroxykaempferol (14) showed the highest activity and was a competitive inhibitor of tyrosinase compared to L-DOPA. 5,6,7-Trihydroxyflavones 1, 6, 13 or 14 showed also high antioxidant activities. Hence, we conclude that the 5,6,7-trihydroxy-flavones are useful as good depigmentation agents with inhibitory effects in addition to their antioxidant properties.